Medizinische Universität Graz - Research portal

Logo MUG Resarch Portal

Publications

Search Items: PROGRESSION-FREE SURVIVAL, . hits: 149

2023

Ascierto, PA; Mandalà, M; Ferrucci, PF; Guidoboni, M; Rutkowski, P; Ferraresi, V; Arance, A; Guida, M; Maiello, E; Gogas, H; Richtig, E; Fierro, MT; Lebbè, C; Helgadottir, H; Queirolo, P; Spagnolo, F; Tucci, M; Del, Vecchio, M; Gonzales, Cao, M; Minisini, AM; De, Placido, S; Sanmamed, MF; Mallardo, D; Curvietto, M; Melero, I; Palmieri, G; Grimaldi, AM; Giannarelli, D; Dummer, R; Chiarion, Sileni, V Sequencing of Ipilimumab Plus Nivolumab and Encorafenib Plus Binimetinib for Untreated BRAF-Mutated Metastatic Melanoma (SECOMBIT): A Randomized, Three-Arm, Open-Label Phase II Trial.
J Clin Oncol. 2023; 41(2): 212-221. Doi: 10.1200/JCO.21.02961
Web of Science PubMed FullText FullText_MUG

 

Brawanski, KR; Sprung, S; Freyschlag, CF; Hoeftberger, R; Ströbel, T; Haybaeck, J; Thomé, C; Manzl, C; Birkl-Toeglhofer, AM Influence of MMR, MGMT Promotor Methylation and Protein Expression on Overall and Progression-Free Survival in Primary Glioblastoma Patients Treated with Temozolomide.
Int J Mol Sci. 2023; 24(7): Doi: 10.3390/ijms24076184 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Pujade-Lauraine, E; Brown, J; Barnicle, A; Wessen, J; Lao-Sirieix, P; Criscione, SW; du, Bois, A; Lorusso, D; Romero, I; Petru, E; Yoshida, H; Vergote, I; Colombo, N; Hietanen, S; Provansal, M; Schmalfeldt, B; Pignata, S; Martín, Lorente, C; Berton, D; Runnebaum, IB; Ray-Coquard, I Homologous Recombination Repair Gene Mutations to Predict Olaparib Plus Bevacizumab Efficacy in the First-Line Ovarian Cancer PAOLA-1/ENGOT-ov25 Trial.
JCO Precis Oncol. 2023; 7:e2200258 Doi: 10.1200/PO.22.00258 [OPEN ACCESS]
PubMed PUBMED Central FullText FullText_MUG

 

2022

Barth, DA; Stanzer, S; Spiegelberg, J; Bauernhofer, T; Absenger, G; Posch, F; Lipp, R; Halm, M; Szkandera, J; Balic, M; Gerger, A; Smolle, MA; Hutterer, GC; Klec, C; Jost, PJ; Kargl, J; Stradner, M; Pichler, M Evaluation of autoantibodies as predictors of treatment response and immune-related adverse events during the treatment with immune checkpoint inhibitors: A prospective longitudinal pan-cancer study.
Cancer Med. 2022; 11(16):3074-3083 Doi: 10.1002/cam4.4675 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Buergy, D; Würschmidt, F; Gkika, E; Hörner-Rieber, J; Knippen, S; Gerum, S; Balermpas, P; Henkenberens, C; Voglhuber, T; Kornhuber, C; Barczyk, S; Röper, B; Rashid, A; Blanck, O; Wittig, A; Herold, HU; Brunner, TB; Sweeney, RA; Kahl, KH; Ciernik, IF; Ottinger, A; Izaguirre, V; Putz, F; König, L; Hoffmann, M; Combs, SE; Guckenberger, M; Boda-Heggemann, J Stereotactic body radiotherapy of adrenal metastases-A dose-finding study.
Int J Cancer. 2022; 151(3): 412-421. Doi: 10.1002/ijc.34017
Web of Science PubMed FullText FullText_MUG

 

Dankner, M; Wang, Y; Fazelzad, R; Johnson, B; Nebhan, CA; Dagogo-Jack, I; Myall, NJ; Richtig, G; Bracht, JWP; Gerlinger, M; Shinozaki, E; Yoshino, T; Kotani, D; Fangusaro, JR; Gautschi, O; Mazieres, J; Sosman, JA; Kopetz, S; Subbiah, V; Davies, MA; Groover, AL; Sullivan, RJ; Flaherty, KT; Johnson, DB; Benedetti, A; Cescon, DW; Spreafico, A; Zogopoulos, G; Rose, AAN Clinical Activity of Mitogen-Activated Protein Kinase-Targeted Therapies in Patients With Non-V600 BRAF-Mutant Tumors.
JCO Precis Oncol. 2022; 6:e2200107 Doi: 10.1200/PO.22.00107
Web of Science PubMed FullText FullText_MUG

 

Feng, J; Li, Y; Wei, B; Guo, L; Li, W; Xia, Q; Zhao, C; Zheng, J; Zhao, J; Sun, R; Guo, Y; Brcic, L; Hakozaki, T; Ying, J; Ma, J Clinicopathologic characteristics and diagnostic methods of RET rearrangement in Chinese non-small cell lung cancer patients.
Transl Lung Cancer Res. 2022; 11(4): 617-631. Doi: 10.21037/tlcr-22-202 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Hecht, M; Eckstein, M; Rutzner, S; von, der, Grün, J; Illmer, T; Klautke, G; Laban, S; Hautmann, MG; Brunner, TB; Tamaskovics, B; Hinke, A; Zhou, JG; Frey, B; Donaubauer, AJ; Becker, I; Semrau, S; Hartmann, A; Balermpas, P; Budach, W; Gaipl, US; Iro, H; Gostian, AO; Fietkau, R Induction chemoimmunotherapy followed by CD8+ immune cell-based patient selection for chemotherapy-free radioimmunotherapy in locally advanced head and neck cancer.
J Immunother Cancer. 2022; 10(1): Doi: 10.1136/jitc-2021-003747 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Kornauth, C; Pemovska, T; Vladimer, GI; Bayer, G; Bergmann, M; Eder, S; Eichner, R; Erl, M; Esterbauer, H; Exner, R; Felsleitner-Hauer, V; Forte, M; Gaiger, A; Geissler, K; Greinix, HT; Gstöttner, W; Hacker, M; Hartmann, BL; Hauswirth, AW; Heinemann, T; Heintel, D; Hoda, MA; Hopfinger, G; Jaeger, U; Kazianka, L; Kenner, L; Kiesewetter, B; Krall, N; Krajnik, G; Kubicek, S; Le, T; Lubowitzki, S; Mayerhoefer, ME; Menschel, E; Merkel, O; Miura, K; Müllauer, L; Neumeister, P; Noesslinger, T; Ocko, K; Öhler, L; Panny, M; Pichler, A; Porpaczy, E; Prager, GW; Raderer, M; Ristl, R; Ruckser, R; Salamon, J; Schiefer, AI; Schmolke, AS; Schwarzinger, I; Selzer, E; Sillaber, C; Skrabs, C; Sperr, WR; Srndic, I; Thalhammer, R; Valent, P; van, der, Kouwe, E; Vanura, K; Vogt, S; Waldstein, C; Wolf, D; Zielinski, CC; Zojer, N; Simonitsch-Klupp, I; Superti-Furga, G; Snijder, B; Staber, PB Functional Precision Medicine Provides Clinical Benefit in Advanced Aggressive Hematologic Cancers and Identifies Exceptional Responders.
Cancer Discov. 2022; 12(2):372-387 Doi: 10.1158/2159-8290.CD-21-0538 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Pratsinis, M; Fankhauser, C; Pratsinis, K; Beyer, J; Bührer, E; Cathomas, R; Fischer, N; Hermanns, T; Hirschi-Blickenstorfer, A; Kamradt, J; Alex, Kluth, L; Zihler, D; Mingrone, W; Müller, B; Nestler, T; Rothschild, SI; Seifert, B; Templeton, AJ; Terbuch, A; Ufen, MP; Woelky, R; Gillessen, S; Rothermundt, C Metastatic Potential of Small Testicular Germ Cell Tumors: Implications for Surveillance of Small Testicular Masses.
Eur Urol Open Sci. 2022; 40: 16-18. Doi: 10.1016/j.euros.2022.03.013 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Rüschoff, JH; Haberecker, M; Tsourti, Z; Nackaerts, K; de, Perrot, M; Brcic, L; Nadal, E; Tsimpoukis, S; Gray, SG; Ampollini, L; Aerts, JG; Felley-Bosco, E; Kirschner, MB; Monkhorst, K; Weynand, B; Bavaghar-Zaeimi, F; Samarzija, M; Llatjos, R; Finn, SP; Silini, E; von, der, Thüsen, J; Marti, N; Vervita, K; Kammler, R; Peters, S; Stahel, RA; Baas, P; Opitz, I, , ETOP, Mesoscape, consortium Expression of phosphorylated ribosomal protein S6 in mesothelioma patients - correlation with clinico-pathological characteristics and outcome: results from the European Thoracic Oncology Platform (ETOP) Mesoscape project.
Mod Pathol. 2022; 35(12):1888-1899 Doi: 10.1038/s41379-022-01145-0 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Strickland, BA; Wedemeyer, M; Ruzevick, J; Micko, A; Shahrestani, S; Daneshmand, S; Shiroishi, MS; Hwang, DH; Attenello, F; Chen, T; Zada, G 5-Aminolevulinic acid-enhanced fluorescence-guided treatment of high-grade glioma using angled endoscopic blue light visualization: technical case series with preliminary follow-up.
J Neurosurg. 2022; 1-9 Doi: 10.3171/2022.1.JNS212562
Web of Science PubMed FullText FullText_MUG

 

2021

Berger, M; Thueringer, A; Franz, D; Dandachi, N; Talakić, E; Richtig, G; Richtig, E; Rohrer, PM; Koch, L; Wolf, IH; Koch, C; Rainer, BM; Koeller, M; Pichler, M; Gerritsmann, H; Kashofer, K; Aigelsreiter, A Circulating Tumor DNA as a Marker for Treatment Response in Metastatic Melanoma Patients Using Next-Generation Sequencing-A Prospective Feasibility Study.
Cancers (Basel). 2021; 13(12): Doi: 10.3390/cancers13123101 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Beyer, J; Collette, L; Sauvé, N; Daugaard, G; Feldman, DR; Tandstad, T; Tryakin, A; Stahl, O; Gonzalez-Billalabeitia, E; De, Giorgi, U; Culine, S; de, Wit, R; Hansen, AR; Bebek, M; Terbuch, A; Albany, C; Hentrich, M; Gietema, JA; Negaard, H; Huddart, RA; Lorch, A; Cafferty, FH; Heng, DYC; Sweeney, CJ; Winquist, E; Chovanec, M; Fankhauser, C; Stark, D; Grimison, P; Necchi, A; Tran, B; Heidenreich, A; Shamash, J; Sternberg, CN; Vaughn, DJ; Duran, I; Bokemeyer, C; Patrikidou, A; Cathomas, R; Assele, S; Gillessen, S, , International, Germ, Cell, Cancer, Classification, Update, Consortium Survival and New Prognosticators in Metastatic Seminoma: Results From the IGCCCG-Update Consortium.
J Clin Oncol. 2021; 39(14):1553-1562 Doi: 10.1200/JCO.20.03292 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Buder, A; Heitzer, E; Waldispühl-Geigl, J; Weber, S; Moser, T; Hochmair, MJ; Hackner, K; Errhalt, P; Setinek, U; Filipits, M Somatic Copy-Number Alterations in Plasma Circulating Tumor DNA from Advanced EGFR-Mutated Lung Adenocarcinoma Patients.
BIOMOLECULES. 2021; 11(5): Doi: 10.3390/biom11050618 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Capdevila, J; Fazio, N; Lopez, C; Teulé, A; Valle, JW; Tafuto, S; Custodio, A; Reed, N; Raderer, M; Grande, E; Garcia-Carbonero, R; Jimenez-Fonseca, P; Hernando, J; Bongiovanni, A; Spada, F; Alonso, V; Antonuzzo, L; Spallanzani, A; Berruti, A; La, Casta, A; Sevilla, I; Kump, P; Giuffrida, D; Merino, X; Trejo, L; Gajate, P; Matos, I; Lamarca, A; Ibrahim, T Lenvatinib in Patients With Advanced Grade 1/2 Pancreatic and Gastrointestinal Neuroendocrine Tumors: Results of the Phase II TALENT Trial (GETNE1509).
J Clin Oncol. 2021; 39(20):2304-2312 Doi: 10.1200/JCO.20.03368
Web of Science PubMed FullText FullText_MUG

 

Domingo-Domenech, E; Duarte, RF; Boumedil, A; Onida, F; Gabriel, I; Finel, H; Arcese, W; Browne, P; Beelen, D; Kobbe, G; Veelken, H; Arranz, R; Greinix, H; Lenhoff, S; Poiré, X; Ribera, JM; Thompson, J; Zuckerman, T; Mufti, GJ; Cortelezzi, A; Olavarria, E; Dreger, P; Sureda, A; Montoto, S Allogeneic hematopoietic stem cell transplantation for advanced mycosis fungoides and Sézary syndrome. An updated experience of the Lymphoma Working Party of the European Society for Blood and Marrow Transplantation.
Bone Marrow Transplant. 2021; 11(2): Doi: 10.1038/s41409-020-01197-3
Web of Science PubMed FullText FullText_MUG

 

Gampenrieder, SP; Rinnerthaler, G; Tinchon, C; Petzer, A; Balic, M; Heibl, S; Schmitt, C; Zabernigg, AF; Egle, D; Sandholzer, M; Singer, CF; Roitner, F; Hager, C; Andel, J; Hubalek, M; Knauer, M; Greil, R Landscape of HER2-low metastatic breast cancer (MBC): results from the Austrian AGMT_MBC-Registry.
BREAST CANCER RES. 2021; 23(1): 112 Doi: 10.1186/s13058-021-01492-x [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Gillessen, S; Sauvé, N; Collette, L; Daugaard, G; de, Wit, R; Albany, C; Tryakin, A; Fizazi, K; Stahl, O; Gietema, JA; De, Giorgi, U; Cafferty, FH; Hansen, AR; Tandstad, T; Huddart, RA; Necchi, A; Sweeney, CJ; Garcia-Del-Muro, X; Heng, DYC; Lorch, A; Chovanec, M; Winquist, E; Grimison, P; Feldman, DR; Terbuch, A; Hentrich, M; Bokemeyer, C; Negaard, H; Fankhauser, C; Shamash, J; Vaughn, DJ; Sternberg, CN; Heidenreich, A; Beyer, J, , International, Germ, Cell, Cancer, Classification, Update, Consortium Predicting Outcomes in Men With Metastatic Nonseminomatous Germ Cell Tumors (NSGCT): Results From the IGCCCG Update Consortium.
J Clin Oncol. 2021; 39(14):1563-1574 Doi: 10.1200/JCO.20.03296 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Hatzl, S; Posch, F; Rezai, A; Gornicec, M; Beham-Schmid, C; Magnes, T; Wangner, S; Deutsch, A; Greinix, H; Uhl, B; Prochazka, KT; Egle, A; Greil, R; Melchardt, T; Linkesch, W; Schulz, E; Neumeister, P Vinorelbine as substitute for vincristine in patients with diffuse large B cell lymphoma and vincristine-induced neuropathy.
Support Care Cancer. 2021; 29(9):5197-5207 Doi: 10.1007/s00520-021-06059-2 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Horak, P; Heining, C; Kreutzfeldt, S; Hutter, B; Mock, A; Hüllein, J; Fröhlich, M; Uhrig, S; Jahn, A; Rump, A; Gieldon, L; Möhrmann, L; Hanf, D; Teleanu, V; Heilig, CE; Lipka, DB; Allgäuer, M; Ruhnke, L; Laßmann, A; Endris, V; Neumann, O; Penzel, R; Beck, K; Richter, D; Winter, U; Wolf, S; Pfütze, K; Geörg, C; Meißburger, B; Buchhalter, I; Augustin, M; Aulitzky, WE; Hohenberger, P; Kroiss, M; Schirmacher, P; Schlenk, RF; Keilholz, U; Klauschen, F; Folprecht, G; Bauer, S; Siveke, JT; Brandts, CH; Kindler, T; Boerries, M; Illert, AL; von, Bubnoff, N; Jost, PJ; Spiekermann, K; Bitzer, M; Schulze-Osthoff, K; von, Kalle, C; Klink, B; Brors, B; Stenzinger, A; Schröck, E; Hübschmann, D; Weichert, W; Glimm, H; Fröhling, S Comprehensive Genomic and Transcriptomic Analysis for Guiding Therapeutic Decisions in Patients with Rare Cancers.
Cancer Discov. 2021; 11(11): 2780-2795. Doi: 10.1158/2159-8290.CD-21-0126
Web of Science PubMed FullText FullText_MUG

 

Kluin-Nelemans, HC; Jawhar, M; Reiter, A; van Anrooij, B; Gotlib, J; Hartmann, K; Illerhaus, A; Elberink, HNGO; Gorska, A; Niedoszytko, M; Lange, M; Scaffidi, L; Zanotti, R; Bonadonna, P; Perkins, C; Elena, C; Malcovati, L; Shoumariyeh, K; von Bubnoff, N; Muller, S; Triggiani, M; Parente, R; Schwaab, J; Kundi, M; Fortina, AB; Caroppo, F; Brockow, K; Zink, A; Fuchs, D; Angelova-Fischer, I; Yavuz, AS; Doubek, M; Mattsson, M; Hagglund, H; Panse, J; Simonowski, A; Sabato, V; Schug, T; Jentzsch, M; Breynaert, C; Varkonyi, J; Kennedy, V; Hermine, O; Rossignol, J; Arock, M; Valent, P; Sperr, WR Cytogenetic and molecular aberrations and worse outcome for male patients in systemic mastocytosis
THERANOSTICS. 2021; 11(1): 292-303. Doi: 10.7150/thno.51872 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Mohamed, AA; Thomsen, A; Follo, M; Zamboglou, C; Bronsert, P; Mostafa, H; Amen, A; Mekawy, M; Grosu, AL; Brunner, TB FAK inhibition radiosensitizes pancreatic ductal adenocarcinoma cells in vitro.
Strahlenther Onkol. 2021; 197(1): 27-38. Doi: 10.1007/s00066-020-01666-0 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Moik, F; Prager, G; Thaler, J; Posch, F; Wiedemann, S; Schramm, T; Englisch, C; Mackman, N; Pabinger, I; Ay, C Hemostatic Biomarkers and Venous Thromboembolism Are Associated With Mortality and Response to Chemotherapy in Patients With Pancreatic Cancer.
Arterioscler Thromb Vasc Biol. 2021; 41(11): 2837-2847. Doi: 10.1161/ATVBAHA.121.316463
Web of Science PubMed FullText FullText_MUG

 

Mollnar, S; Pondorfer, P; Kasparek, AK; Reinisch, S; Moik, F; Stotz, M; Halm, M; Szkandera, J; Terbuch, A; Eisner, F; Gerger, A; Kapp, KS; Partl, R; Vasicek, S; Weiland, T; Pichler, M; Stöger, H; Thurnher, D; Posch, F Decrease in treatment intensity predicts worse outcome in patients with locally advanced head and neck squamous cell carcinoma undergoing radiochemotherapy.
Clin Transl Oncol. 2021; 23(3):543-553 Doi: 10.1007/s12094-020-02447-y [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Pink, D; Andreou, D; Bauer, S; Brodowicz, T; Kasper, B; Reichardt, P; Richter, S; Lindner, LH; Szkandera, J; Gruenwald, V; Kebenko, M; Kirchner, M; Hohenberger, P Treatment of Angiosarcoma with Pazopanib and Paclitaxel: Results of the EVA (Evaluation of Votrient(R) in Angiosarcoma) Phase II Trial of the German Interdisciplinary Sarcoma Group (GISG-06)
CANCERS. 2021; 13(6): 1223 Doi: 10.3390/cancers13061223 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Prager, GW; Oehler, L; Gerger, A; Mlineritsch, B; Andel, J; Petzer, A; Wilthoner, K; Sliwa, T; Pichler, P; Winder, T; Heibl, S; Gruenberger, B; Laengle, F; Hubmann, E; Korger, M; Pecherstorfer, M; Djanani, A; Neumann, HJ; Philipp-Abbrederis, K; Wöll, E; Trondl, R; Arnold-Schrauf, C; Eisterer, W Comparison of nab-paclitaxel plus gemcitabine in elderly versus younger patients with metastatic pancreatic cancer: Analysis of a multicentre, prospective, non-interventional study.
Eur J Cancer. 2021; 143:101-112 Doi: 10.1016/j.ejca.2020.11.003 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Riedl, JM; Hasenleithner, SO; Pregartner, G; Scheipner, L; Posch, F; Groller, K; Kashofer, K; Jahn, SW; Bauernhofer, T; Pichler, M; Stöger, H; Berghold, A; Hoefler, G; Speicher, MR; Heitzer, E; Gerger, A Profiling of circulating tumor DNA and tumor tissue for treatment selection in patients with advanced and refractory carcinoma: a prospective, two-stage phase II Individualized Cancer Treatment trial.
Ther Adv Med Oncol. 2021; 13:1758835920987658 Doi: 10.1177/1758835920987658 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Riedl, JM; Posch, F; Horvath, L; Gantschnigg, A; Renneberg, F; Schwarzenbacher, E; Moik, F; Barth, DA; Rossmann, CH; Stotz, M; Schaberl-Moser, R; Pichler, M; Stöger, H; Greil, R; Djanani, A; Schlick, K; Gerger, A Gemcitabine/nab-Paclitaxel versus FOLFIRINOX for palliative first-line treatment of advanced pancreatic cancer: A propensity score analysis.
Eur J Cancer. 2021; 151: 3-13. Doi: 10.1016/j.ejca.2021.03.040 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Rinnerthaler, G; Gampenrieder, SP; Petzer, A; Hubalek, M; Petru, E; Sandholzer, M; Andel, J; Balic, M; Melchardt, T; Hauser-Kronberger, C; Schmitt, CA; Ulmer, H; Greil, R Capecitabine in combination with bendamustine in pretreated women with HER2-negative metastatic breast cancer: results of a phase II trial (AGMT MBC-6).
Ther Adv Med Oncol. 2021; 13: 17588359211042301 Doi: 10.1177/17588359211042301 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Seeber, A; Weiss, L; Romeder, F; Szkandera, J; Kuehr, T; Kostner, S; Pichler, P; Jaeger, T; Kocher, F; Greil, R; Brodowicz, T Olaratumab plus anthracyline in advanced/metastatic soft tissue sarcoma : Data of real-world utilization in Austria.
Wien Klin Wochenschr. 2021; 133(1-2):21-25 Doi: 10.1007/s00508-019-01556-1
Web of Science PubMed FullText FullText_MUG

 

Temesfői, V; Herczeg, R; Lőcsei, Z; Sebestyén, K; Sebestyén, Z; Mangel, L; Damásdi, M Should We Reconsider the Necessity of a Refinement of Prostate Cancer Risk Classification and Radiotherapy Treatment Strategy? Experiences from a Retrospective Analysis of Data from a Single Institution.
J Clin Med. 2020; 10(1): Doi: 10.3390/jcm10010110 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Weber, S; van der Leest, P; Donker, HC; Schlange, T; Timens, W; Tamminga, M; Hasenleithner, SO; Graf, R; Moser, T; Spiegl, B; Yaspo, ML; Terstappen, LWMM; Sidorenkov, G; Hiltermann, TJN; Speicher, MR; Schuuring, E; Heitzer, E; Groen, HJM Dynamic Changes of Circulating Tumor DNA Predict Clinical Outcome in Patients With Advanced Non-Small-Cell Lung Cancer Treated With Immune Checkpoint Inhibitors
JCO PRECIS ONCOL. 2021; 5: 1540-1553. Doi: 10.1200/PO.21.00182
Web of Science PubMed FullText FullText_MUG

 

2020

Bianconi, D; Herac, M; Posch, F; Schmeidl, M; Unseld, M; Kieler, M; Brettner, R; Mullauer, L; Riedl, J; Gerger, A; Scheithauer, W; Prager, G Microvascular density assessed by CD31 predicts clinical benefit upon bevacizumab treatment in metastatic colorectal cancer: results of the PassionATE study, a translational prospective Phase II study of capecitabine and irinotecan plus bevacizumab followed by capecitabine and oxaliplatin plus bevacizumab or the reverse sequence in patients in mCRC.
THER ADV MED ONCOL. 2020; 12: 1758835920928635 Doi: 10.1177/1758835920928635 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Brodowicz, T; Liegl-Atzwanger, B; Penel, N; Mir, O; Blay, JY; Kashofer, K; Le Cesne, A; Decoupigny, E; Wallet, J; Hamacher, R; Deley, ML Assessing Prognostic and Predictive Biomarkers of Regorafenib Response in Patients with Advanced Soft Tissue Sarcoma: REGOSARC Study.
Cancers (Basel). 2020; 12(12): Doi: 10.3390/cancers12123746 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Dietzsch, S; Placzek, F; Pietschmann, K; von Bueren, AO; Matuschek, C; Glück, A; Guckenberger, M; Budach, V; Welzel, J; Pöttgen, C; Schmidberger, H; Heinzelmann, F; Paulsen, F; Escudero, MP; Schwarz, R; Hornung, D; Martini, C; Grosu, AL; Stueben, G; Jablonska, K; Dunst, J; Stranzl-Lawatsch, H; Dieckmann, K; Timmermann, B; Pietsch, T; Warmuth-Metz, M; Bison, B; Kwiecien, R; Benesch, M; Gerber, NU; Grotzer, MA; Pfister, SM; Clifford, SC; von Hoff, K; Klagges, S; Rutkowski, S; Kortmann, RD; Mynarek, M Evaluation of Prognostic Factors and Role of Participation in a Randomized Trial or a Prospective Registry in Pediatric and Adolescent Nonmetastatic Medulloblastoma - A Report From the HIT 2000 Trial.
Adv Radiat Oncol. 2020; 5(6): 1158-1169. Doi: 10.1016/j.adro.2020.09.018 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Dummer, R; Lebbé, C; Atkinson, V; Mandalà, M; Nathan, PD; Arance, A; Richtig, E; Yamazaki, N; Robert, C; Schadendorf, D; Tawbi, HA; Ascierto, PA; Ribas, A; Flaherty, KT; Pakhle, N; Campbell, CD; Gusenleitner, D; Masood, A; Brase, JC; Gasal, E; Long, GV Combined PD-1, BRAF and MEK inhibition in advanced BRAF-mutant melanoma: safety run-in and biomarker cohorts of COMBI-i.
Nat Med. 2020; 26(10): 1557-1563. Doi: 10.1038/s41591-020-1082-2
Web of Science PubMed FullText FullText_MUG

 

Elbelt, U; Schlaffer, SM; Buchfelder, M; Knappe, UJ; Vila, G; Micko, A; Deutschbein, T; Unger, N; Lammert, A; Topuzoglu-Müller, T; Bojunga, J; Droste, M; Johanssen, S; Kolenda, H; Ritzel, K; Buslei, R; Strasburger, CJ; Petersenn, S; Honegger, J Efficacy of Temozolomide Therapy in Patients With Aggressive Pituitary Adenomas and Carcinomas-A German Survey.
J Clin Endocrinol Metab. 2020; 105(3): Doi: 10.1210/clinem/dgz211
Web of Science PubMed FullText FullText_MUG

 

Fischer, S; Tandstad, T; Cohn-Cedermark, G; Thibault, C; Vincenzi, B; Klingbiel, D; Albany, C; Necchi, A; Terbuch, A; Lorch, A; Aparicio, J; Heidenreich, A; Hentrich, M; Wheater, M; Langberg, CW; Ståhl, O; Fankhauser, CD; Hamid, AA; Koutsoukos, K; Shamash, J; White, J; Bokemeyer, C; Beyer, J; Gillessen, S, , Global, Germ-Cell, Cancer, Group Outcome of Men With Relapses After Adjuvant Bleomycin, Etoposide, and Cisplatin for Clinical Stage I Nonseminoma.
J Clin Oncol. 2020; 38(12):1322-1331 Doi: 10.1200/JCO.19.01876 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Harter, P; Pautier, P; Van Nieuwenhuysen, E; Reuss, A; Redondo, A; Lindemann, K; Kurzeder, C; Petru, E; Heitz, F; Sehouli, J; Degregorio, N; Wimberger, P; Burges, A; Cron, N; Ledermann, J; Lorusso, D; Paoletti, X; Marme, F Atezolizumab in combination with bevacizumab and chemotherapy versus bevacizumab and chemotherapy in recurrent ovarian cancer - a randomized phase III trial (AGO-OVAR 2.29/ENGOT-ov34).
Int J Gynecol Cancer. 2020; 30(12): 1997-2001. Doi: 10.1136/ijgc-2020-001572
Web of Science PubMed FullText FullText_MUG

 

Hatzl, S; Posch, F; Deutsch, A; Beham-Schmid, C; Stöger, H; Greinix, H; Pichler, M; Neumeister, P; Prochazka, KT Immunohistochemistry for c-myc and bcl-2 overexpression improves risk stratification in primary central nervous system lymphoma.
Hematol Oncol. 2020; 38(3):277-283 Doi: 10.1002/hon.2727 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Kluin-Nelemans, HC; Reiter, A; Illerhaus, A; van Anrooij, B; Hartmann, K; Span, LFR; Gorska, A; Niedoszytko, M; Lange, M; Scaffidi, L; Zanotti, R; Bonadonna, P; Perkins, C; Elena, C; Malcovati, L; Shoumariyeh, K; von Bubnoff, N; Parente, R; Triggiani, M; Schwaab, J; Jawhar, M; Caroppo, F; Fortina, AB; Brockow, K; Zink, A; Fuchs, D; Kilbertus, A; Yavuz, AS; Doubek, M; Mattsson, M; Hagglund, H; Panse, J; Sabato, V; Aberer, E; Niederwieser, D; Breynaert, C; Várkonyi, J; Kennedy, V; Lortholary, O; Jakob, T; Hermine, O; Rossignol, J; Arock, M; Gotlib, J; Valent, P; Sperr, WR Prognostic impact of eosinophils in mastocytosis: analysis of 2350 patients collected in the ECNM Registry.
Leukemia. 2020; 34(4):1090-1101 Doi: 10.1038/s41375-019-0632-4 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Krug, S; Weissbach, J; Blank, A; Perren, A; Haybaeck, J; Fendrich, V; Rinke, A; Gress, TM; Rosendahl, J; Michl, P CUX1-Transcriptional Master Regulator of Tumor Progression in Pancreatic Neuroendocrine Tumors.
Cancers (Basel). 2020; 12(7): Doi: 10.3390/cancers12071957 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Lőcsei, Z; Farkas, R; Borbásné, Farkas, K; Sebestyén, K; Sebestyén, Z; Musch, Z; Vojcek, Á; Benedek, N; Mangel, L; Ottóffy, G Assessment of the results and hematological side effects of 3D conformal and IMRT/ARC therapies delivered during craniospinal irradiation of childhood tumors with a follow-up period of five years.
BMC Cancer. 2020; 20(1): 702 Doi: 10.1186/s12885-020-07168-7 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Moritz, J; Bauernhofer, T; Mannweiler, S; Langsenlehner, T; Pummer, K; Dandachi, N; Pichler, M Evaluation of Blood-based Biomarkers for Prediction of Response in Carboplatin-treated Metastatic Castration-resistant Prostate Cancer Patients.
In Vivo. 2020; 34(6): 3631-3638. Doi: 10.21873/invivo.12209 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Mynarek, M; von Hoff, K; Pietsch, T; Ottensmeier, H; Warmuth-Metz, M; Bison, B; Pfister, S; Korshunov, A; Sharma, T; Jaeger, N; Ryzhova, M; Zheludkova, O; Golanov, A; Rushing, EJ; Hasselblatt, M; Koch, A; Schüller, U; von Deimling, A; Sahm, F; Sill, M; Riemenschneider, MJ; Dohmen, H; Monoranu, CM; Sommer, C; Staszewski, O; Mawrin, C; Schittenhelm, J; Brück, W; Filipski, K; Hartmann, C; Meinhardt, M; Pietschmann, K; Haberler, C; Slavc, I; Gerber, NU; Grotzer, M; Benesch, M; Schlegel, PG; Deinlein, F; von Bueren, AO; Friedrich, C; Juhnke, BO; Obrecht, D; Fleischhack, G; Kwiecien, R; Faldum, A; Kortmann, RD; Kool, M; Rutkowski, S Nonmetastatic Medulloblastoma of Early Childhood: Results From the Prospective Clinical Trial HIT-2000 and An Extended Validation Cohort.
J Clin Oncol. 2020; 38(18):2028-2040 Doi: 10.1200/JCO.19.03057
Web of Science PubMed FullText FullText_MUG

 

Penack, O; Peczynski, C; van der Werf, S; Finke, J; Ganser, A; Schoemans, H; Pavlu, J; Niittyvuopio, R; Schroyens, W; Kaynar, L; Blau, IW; van der Velden, WJFM; Sierra, J; Cortelezzi, A; Wulf, G; Turlure, P; Rovira, M; Ozkurt, Z; Pascual-Cascon, MJ; Moreira, MC; Clausen, J; Greinix, H; Duarte, RF; Basak, GW Association of Serum Ferritin Levels Before Start of Conditioning With Mortality After alloSCT - A Prospective, Non-interventional Study of the EBMT Transplant Complications Working Party.
Front Immunol. 2020; 11:586-586 Doi: 10.3389/fimmu.2020.00586 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Petzer, AL; Sperr, WR; Buxhofer-Ausch, V; Sliwa, T; Schmidt, S; Greil, R; Wölfler, A; Pichler, P; Dormann, C; Burgstaller, S; Tinchon, C; Lang, A; Goebel, F; Uthman, S; Muenchmeier, N; Valent, P A multicenter retrospective evaluation of Chronic Myeloid Leukemia (CML) therapy in Austria assessing the impact of early treatment response on patient outcomes in a real-life setting : R-EFECT study.
Wien Klin Wochenschr. 2020; Doi: 10.1007/s00508-020-01690-1 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Rendl, G; Sipos, B; Becherer, A; Sorko, S; Trummer, C; Raderer, M; Hitzl, W; Ardelt, M; Gallowitsch, HJ; Pirich, C Real-World Data for Lenvatinib in Radioiodine-Refractory Differentiated Thyroid Cancer (RELEVANT): A Retrospective Multicentric Analysis of Clinical Practice in Austria.
INT J ENDOCRINOL. 2020; 2020(6): 8834148-8834148. Doi: 10.1155/2020/8834148 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Riedl, JM; Barth, DA; Brueckl, WM; Zeitler, G; Foris, V; Mollnar, S; Stotz, M; Rossmann, CH; Terbuch, A; Balic, M; Niedrist, T; Bertsch, T; Stoeger, H; Pichler, M; Olschewski, H; Absenger, G; Ficker, JH; Gerger, A; Posch, F C-Reactive Protein (CRP) Levels in Immune Checkpoint Inhibitor Response and Progression in Advanced Non-Small Cell Lung Cancer: A Bi-Center Study.
Cancers (Basel). 2020; 12(8): Doi: 10.3390/cancers12082319 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Show the next 50 results of search

↑ Top of page / Navigation

© Med Uni Graz • Imprint